|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Breast cancer
Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine
Hyunwoo Lee, Yoon Ah Cho, Deok Geun Kim, Eun Yoon Cho
Cancer Res Treat.
2024;56(1):149-161. Published online August 11, 2023 DOI:
https://doi.org/10.4143/crt.2023.800
PIK3CA
Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients
Ju Won Kim, Ah Reum Lim, Ji Young You, Jung Hyun Lee, Sung Eun Song, Nam Kwon Lee, Seung Pil Jung, Kyu Ran Cho, Cheol Yong Kim, Kyong Hwa Park
Cancer Res Treat.
2023;55(2):531-541. Published online September 7, 2022 DOI:
https://doi.org/10.4143/crt.2022.221
Web of Science 5
Crossref 6
Analysis of
PIK3CA
Mutation Concordance and Frequency in Primary and Different Distant Metastatic Sites in Breast Cancer
Jieun Park, Soo Youn Cho, Eun Sol Chang, Minjung Sung, Ji-Young Song, Kyungsoo Jung, Sung-Su Kim, Young Kee Shin, Yoon-La Choi
Cancer Res Treat.
2023;55(1):145-154. Published online April 20, 2022 DOI:
https://doi.org/10.4143/crt.2022.001
Web of Science 2
Crossref 2
Gynecologic cancer
Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic
PIK3CA
or
KRAS
Mutations
Aiko Ogasawara, Taro Hihara, Daisuke Shintani, Akira Yabuno, Yuji Ikeda, Kenji Tai, Keiichi Fujiwara, Keisuke Watanabe, Kosei Hasegawa
Cancer Res Treat.
2020;52(4):1219-1228. Published online May 6, 2020 DOI:
https://doi.org/10.4143/crt.2019.688
Web of Science 12
Crossref 4
PIK3CA
H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert
Cancer Res Treat.
2020;52(3):689-696. Published online February 4, 2020 DOI:
https://doi.org/10.4143/crt.2019.497
Web of Science 27
Crossref 25
Prevalence and Prognostic Role of
PIK3CA
/AKT1
Mutations in Chinese Breast Cancer Patients
Ling Deng, Xuehua Zhu, Yun Sun, Jiemin Wang, Xiaorong Zhong, Jiayuan Li, Min Hu, Hong Zheng
Cancer Res Treat.
2019;51(1):128-140. Published online March 15, 2018 DOI:
https://doi.org/10.4143/crt.2017.598
Web of Science 25
Crossref 22
Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
Min-Young Lee, Bo Mi Ku, Hae Su Kim, Ji Yun Lee, Sung Hee Lim, Jong-Mu Sun, Se-Hoon Lee, Keunchil Park, Young Lyun Oh, Mineui Hong, Han-Sin Jeong, Young-Ik Son, Chung-Hwan Baek, Myung-Ju Ahn
Cancer Res Treat.
2017;49(4):906-914. Published online December 26, 2016 DOI:
https://doi.org/10.4143/crt.2016.424
Web of Science 18
Crossref 16
A Phase II Study of Poziotinib in Patients with Epidermal Growth Factor Receptor (
EGFR
)-Mutant Lung Adenocarcinoma Who Have Acquired Resistance to EGFR–Tyrosine Kinase Inhibitors
Ji-Youn Han, Ki Hyeong Lee, Sang-We Kim, Young Joo Min, Eunkyung Cho, Youngjoo Lee, Soo-Hyun Lee, Hyae Young Kim, Geon Kook Lee, Byung Ho Nam, Hyesun Han, Jina Jung, Jin Soo Lee
Cancer Res Treat.
2017;49(1):10-19. Published online May 3, 2016 DOI:
https://doi.org/10.4143/crt.2016.058
Web of Science 35
Crossref 33
1
Journal Impact Factor 4.6
> Browse Articles > Search
